Frequency of movement disorders in an Ethiopian University practice

Movement Disorders

Volumn 20, Issue 9, 2005, Pages 1209-1213

  Bower, James H ^a   Teshome, Mesfin ^b   Melaku, Zenebe ^b   Zenebe, Guta ^b  

^a Mayo Clinic   (United States)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

Africa; Movement disorders; Parkinsonism; Prevalence

Indexed keywords

ACETYLSALICYLIC ACID; AMANTADINE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; BROMAZEPAM; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CHLORPROMAZINE; CLONAZEPAM; DIAZEPAM; HALOPERIDOL; LEVODOPA; LIMBITROL; NEUROLEPTIC AGENT; PENICILLIN G; PHENOBARBITAL; PHENYTOIN; PRAMIPEXOLE; PRIMIDONE; PROPRANOLOL; THIORIDAZINE; TRIHEXYPHENIDYL; VITAMIN;

ADULT; AGED; ARTICLE; ATAXIA; CHOREA; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DRUG COST; DYSTONIA; ECHOCARDIOGRAPHY; ESSENTIAL TREMOR; ETHIOPIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL PRACTICE; MEDICAL RECORD; MOTOR DYSFUNCTION; MYELOGRAPHY; NEUROLOGIC DISEASE; OUTPATIENT DEPARTMENT; PARKINSONISM; PATIENT CARE; PRIORITY JOURNAL; SPINE RADIOGRAPHY; THORAX RADIOGRAPHY; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; ATAXIA; CATCHMENT AREA (HEALTH); DYSTONIA; ESSENTIAL TREMOR; ETHIOPIA; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOVEMENT DISORDERS; NEUROLOGY; PARKINSONIAN DISORDERS; STUDENT HEALTH SERVICES;

EID: 27744460634     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20567     Document Type: Article

References (28)

1. Schoenberg BS, Osuntokun BO, Adeuja AO, et al. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 1988;38:645-646.
2. Zhang ZX, Roman GC. Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 1993; 12:195-208.
3. Osuntokun BO, Adeuja AO, Schoenberg BS, et al. Neurological disorders in Nigerian Africans: a community-based study. Acta Neurol Scand 1987;75:13-21.
4. Eastham JH, Lacro JP, Jeste DV. Ethnicity and movement disorders. Mt Sinai J Med 1996;63:314-319.
5. Jendroska K, Olasode BJ, Daniel SE, et al. Incidental Lewy body disease in black Africans. Lancet 1994;344:882-883.
6. Ashok PP, Radhakrishnan K, Sridharan R, Mousa ME. Epidemiology of Parkinson's disease in Benghazi, north-east Libya. Clin Neurol Neurosurg 1986;88:109-113.
7. Richards M, Chaudhuri KR. Parkinson's disease in populations of African origin: a review. Neuroepidemiology 1996;15:214-221.
8. Osuntokun BO, Bademosi O. Parkinsonism in the Nigerian African: a prospective study of 217 patients. East Aft Med J 1979;56: 597-607.
9. Lombard A, Gelfand M. Parkinson's disease in the African. Cent Aft J Med 1978;24:5-8.
10. Kessler II. Epidemiologic studies of Parkinson's disease: II, a hospital-based survey. Am J Epidemiol 1972;95:308-318.
11. Haimanot RT. Parkinson's disease in Ethiopia: a prospective study of 70 patients. East Aft Med J 1985;62:571-579.
12. Aiyesimoju AB, Osuntokun BO, Bademosi O, Adeuja AO. Hereditary neurodegenerative disorders in Nigerian Africans. Neurology 1984;34:361-362.
13. Hayden MR, MacGregor JM, Saffer DS, Beighton PH. The high frequency of juvenile Huntington's chorea in South Africa. J Med Genet 1982;19:94-97.
14. Holden TJ, Sandler R, Myslobodsky M. Tardive dyskinesia: prevalence and subtypes at Valkenberg Hospital, Cape Town. S Aft Med J 1984;66:132-134.
15. Ogunniyi A. Treatment of parkinsonian syndromes in developing countries. Aft J Med Med Sci 1997;26:101-103.
16. Murray C, Lopez A. The global burden of disease. Geneva: World Health Organization; 1996.
17. Bergen DC, Silberberg D. Nervous system disorders: a global epidemic. Arch Neurol 2002;59:1194-1196.
18. Menken M. Neurologic care and the care provided by neurologists: implications of the World Federation of Neurology workforce survey. J Neurol Sci 2002;198:1-2.
19. Bergen DC. Preventable neurological diseases worldwide. Neuroepidemiology 1998;17:67-73.
20. Menken M, Munsat TL, Toole JF. The global burden of disease study: implications for neurology. Arch Neurol 2000;57:418-420.
21. World Bank. The World Bank group data by country. Geneva: World Bank. Available at http://www.worldbank.org/data/countrydata/countrydata.html; accessed 28 October 2004.
22. Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology 1985;35:841-845.
23. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol 1995;142:820-927.
24. Chaudhuri KR, Hu MT, Brooks DJ. Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK. Mov Disord 2000;15:18-23.
25. Hu MT, Chaudhuri KR, Jarosz J, Yaguez L, Brooks DJ. An imaging study of parkinsonism among African-Caribbean and Indian London communities. Mov Disord 2002;17:1321-1328.
26. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999;52:1214-1220.
27. Kumar N, Van Gerpen J, Bower JH, Ahlskog J. Levodopa-dyskinesia incidence by age of Parkinson's disease onset. Mov Disord 2005;20:342-344.
28. Countries CoNSDiD, Health BoG, Medicine to. Neurological, psychiatric, and developmental disorders: meeting the challenges in the developing world. Washington, DC: National Academy Press; 2003.